Published January 1, 2024 | Version v1
Publication Open

Updating cancer research with patient-focused networks

Authors/Creators

  • 1. ROR icon Spanish National Cancer Research Centre

Description

Multidisciplinary patient-centered networks offer access to difficultto-get samplesandinitiateprojects from human material. Improving such networks to include ‘living’ samples could be transformative, not only for research but for clinical trial design, especially when focused on unmet clinical needs, such as brain metastasis.

Technical info

We thank all members of the Brain Metastasis Group, the CNIO Biobank, and RENACER for their contributions to create and develop this initiative. We want to thank GEPAC for their support and CNIO Core Facilities for their excellent assistance. Weare especially grateful to patients who donated their samples. RENACER and all associated studies have been developed thanks to funding received from Fundación Ramón Areces [CIVP20S10662 (E.O.P.) and CIVP19S8163 (M.V.)]; ISCIII (PT20/ 00070) (E.O.P.); Worldwide Cancer Research (190177) (M.V.); H2020-FETOPEN-2018-2019-202001 (828972) (M.V.); AECC (LABAE19002VALI) (M.V.); ERC CoG (864759) (M.V.); The Mark Foundation (21-05-ASP) (M.V.); MICINN/AEI/10.13039/ 501100011033 by the European Regional Development Fund (ERDF-EU) (PID2021-124582OB-I00) (M.V.); ERANET-TRANSCAN-3 (TRANSCAN20212023) (M.V.) with funds from Instituto de Salud Carlos III/NextGenerationEU/PRTR (AC20/00114) and FC AECC (TRNSC213878VALI); and AstraZeneca (10049582/5522) (M.V.).

Files

1-s2.0-S2405803323001863-main.pdf

Files (861.3 kB)

Name Size Download all
md5:a00255e4288bf7697d2c37da40a163fb
861.3 kB Preview Download

Additional details

Funding

European Commission
NanoBRIGHT - BRInGing nano-pHoTonics into the brain 828972
European Commission
ALTER-brain - Metastasis-associated altered molecular patterns in the brain 864759

Dates

Available
2024-01-01